CRBP Corbus Pharmaceuticals Holdings Inc

Corbus Pharmaceuticals Holdings Inc is a biopharmaceutical company. Its business involves the development of therapeutics to address serious inflammatory diseases such as cystic fibrosis, systemic sclerosis and skin-predominant dermatomyositis.

$0.13
As of 12/02/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/27/2014
Outstanding shares:  18,965,090
Average volume:  9,325,520
Market cap:   $2,869,418
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   -0.12
PB ratio:   0.40
PS ratio:   0.00
Return on equity:   -63.79%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy